Drug news
NICE now recommends Iluvien (Alimera Sciences) for DME
In draft guidance NICE (National Institute for Health and Care Excellence) now recommends Iluvien (fluocinolone acetonide), a fluocinolone acetonide intravitreal implant, from Alimera Sciences, for certain patients with chronic Diabetic Macular Oedema after Alimera Sciences offered a discount for the treatment.
Around 336,000 people with diabetes in the UK have diabetic macular oedema. The condition can cause blurred or double vision in those affected.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.